Trinity Capital Inc. Continues Life Sciences Growth, Hires Industry Veteran Ryan Kaeding as Managing Director

Rhea-AI Summary

Trinity Capital Inc. (NASDAQ: TRIN) announced the appointment of Ryan Kaeding as Managing Director, Life Sciences in San Diego, California. With over 20 years of experience in the venture ecosystem and 12 years in healthcare investment banking, Mr. Kaeding is expected to drive impactful investments in the life sciences industry. His expertise is a valuable addition to Trinity's continued success.

PHOENIX, Dec. 18, 2023 /PRNewswire/ -- Trinity Capital Inc. (NASDAQ: TRIN) ("Trinity" or the "Company"), a leading provider of diversified financial solutions to growth-stage companies, today announced the appointment of Ryan Kaeding as Managing Director, Life Sciences in San Diego, California. Mr. Kaeding, a veteran in the venture ecosystem, has been supporting venture capital-backed growth-stage companies for 20+ years.

"We are thrilled to welcome Ryan to our team in San Diego," said Rob Lake, Senior Managing Director, Life Sciences at Trinity. "His expertise is expected to be a valuable addition to our continued success, and we look forward to driving more impactful investments in the life sciences industry."

Mr. Kaeding joins Trinity following 12 years of healthcare investment banking experience, most recently as a Managing Director at Raymond James and 10 years at Piper Sandler. Kaeding has completed over 70 healthcare transactions, spanning sell-side and buy-side M&A, IPOs, public and private financings, structured financings, divestitures, spin-offs, converts and debt financings. Previously, Kaeding worked at St. Jude Medical in business development for the cardiovascular division and began his career for five years as a CPA at Deloitte. Mr. Kaeding also holds the Chartered Financial Analyst designation.

"I am honored to join this exceptional team with a remarkable track record," said Mr. Kaeding. "I am excited to partner with innovative, growth-stage life science companies and contribute to our shared mission of driving improvements in care for the life sciences sector."

About Trinity Capital Inc.
Trinity Capital Inc. (Nasdaq: TRIN), an internally managed business development company, is a leading provider of diversified financial solutions to growth-stage companies with institutional equity investors. Trinity Capital's investment objective is to generate current income and, to a lesser extent, capital appreciation through investments, including term loans and equipment financings and equity-related investments. Trinity Capital believes it is one of only a select group of specialty lenders that has the depth of knowledge, experience and track record in lending to growth stage companies. For more information, please visit the Company's website at www.trinitycap.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/trinity-capital-inc-continues-life-sciences-growth-hires-industry-veteran-ryan-kaeding-as-managing-director-302017370.html

SOURCE Trinity Capital Inc.

FAQ

Who is the new Managing Director of Life Sciences at Trinity Capital Inc. (NASDAQ: TRIN)?

Ryan Kaeding has been appointed as the new Managing Director of Life Sciences at Trinity Capital Inc.

What is the background of Ryan Kaeding, the new Managing Director at Trinity Capital Inc. (NASDAQ: TRIN)?

Ryan Kaeding has over 20 years of experience in the venture ecosystem and 12 years in healthcare investment banking. He has completed over 70 healthcare transactions and holds the Chartered Financial Analyst designation.

What is the focus of Trinity Capital Inc. (NASDAQ: TRIN) in the life sciences industry?

Trinity Capital Inc. focuses on providing diversified financial solutions to growth-stage companies in the life sciences industry.

What are the expectations from the appointment of Ryan Kaeding at Trinity Capital Inc. (NASDAQ: TRIN)?

The appointment of Ryan Kaeding is expected to drive impactful investments in the life sciences industry and contribute to Trinity's continued success.